Sexual Dimorphism in Cardiometabolic Diseases: The Role of AMPK
International Journal of Molecular Sciences · 2023
DOI: 10.3390/ijms241511986 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Miroslava Kvandova und 2 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Normal and Pathological Physiology, Centre of Experimental Medicine, Slovak Academy of Sciences, 841 04 Bratislava, Slovakia. Hauptthemen laut MEDLINE: Cardiovascular Diseases. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 178 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: H2020 Marie Skłodowska-Curie Actions, Vedecká Grantová Agentúra MŠVVaŠ SR a SAV, Agentúra na Podporu Výskumu a Vývoja.
Abstract (Originalsprache)
Cardiovascular diseases (CVDs) are the leading cause of mortality and disability among both males and females. The risk of cardiovascular diseases is heightened by the presence of a risk factor cluster of metabolic syndrome, covering obesity and obesity-related cardiometabolic risk factors such as hypertension, glucose, and lipid metabolism dysregulation primarily. Sex hormones contribute to metabolic regulation and make women and men susceptible to obesity development in a different manner, which necessitates sex-specific management. Identifying crucial factors that protect the cardiovascular system is essential to enhance primary and secondary prevention of cardiovascular diseases and should be explicitly studied from the perspective of sex differences. It seems that AMP-dependent protein kinase (AMPK) may be such a factor since it has the protective role of AMPK in the cardiovascular system, has anti-diabetic properties, and is regulated by sex hormones. Those findings highlight the potential cardiometabolic benefits of AMPK, making it an essential factor to consider. Here, we review information about the cross-talk between AMPK and sex hormones as a critical point in cardiometabolic disease development and progression and a target for therapeutic intervention in human disease.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Normal and Pathological Physiology, Centre of Experimental Medicine, Slovak Academy of Sciences, 841 04 Bratislava, Slovakia.
ORCID-Profile: Miroslava Kvandova, Angelika Puzserova
Förderung
- H2020 Marie Skłodowska-Curie Actions
- Vedecká Grantová Agentúra MŠVVaŠ SR a SAV
- Agentúra na Podporu Výskumu a Vývoja
Zitieren
APA
Kvandova, M., Puzserova, A., & Balis, P. (2023). Sexual Dimorphism in Cardiometabolic Diseases: The Role of AMPK. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms241511986
Vancouver
Kvandova M, Puzserova A, Balis P. Sexual Dimorphism in Cardiometabolic Diseases: The Role of AMPK. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms241511986
BibTeX
@article{Kvandova2023,
author = {Kvandova, Miroslava and Puzserova, Angelika and Balis, Peter},
title = {Sexual Dimorphism in Cardiometabolic Diseases: The Role of AMPK},
journal = {International Journal of Molecular Sciences},
year = {2023},
doi = {10.3390/ijms241511986}
}
EUVIMED